Leadership & Pay ·
Jasper CFO Herb Cross resigns; CEO Jeet Mahal named interim principal financial officer
JSPRJasper Therapeutics, Inc.
Jasper Therapeutics, Inc. reported that Chief Financial Officer Herb Cross resigned effective October 9, 2026, to pursue other professional endeavors. The Board appointed President and CEO Jeet Mahal as interim Principal Financial Officer, Vice President of Finance Rick Ruiz as interim Principal Accounting Officer, and COO Matthew Ros as interim Corporate Secretary. Mr. Ruiz will retain his current base salary of $364,000 per year and remains eligible for equity awards but received no new grants in connection with these interim appointments. Jasper Therapeutics operates in the biotechnology industry, focusing on developing therapies for rare genetic diseases.